The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Esmeron 10 mg/ml solution for injection/infusion



Merck Sharp & Dohme Ireland (Human Health) LimitedPA1286/058/001

Main Information

Trade NameEsmeron 10 mg/ml solution for injection/infusion
Active SubstancesRocuronium bromide
Dosage FormSolution for injection/infusion
Licence HolderMerck Sharp & Dohme Ireland (Human Health) Limited
Licence NumberPA1286/058/001

Group Information

ATC CodeM03AC Other quaternary ammonium compounds
M03AC09 rocuronium bromide

Status

License statusAuthorised
Licence Issued07/08/1996
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back